PMID: 2242327Sep 1, 1990

The pathophysiology of Sandimmune (cyclosporine) in man and animals

Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
J Mason

Abstract

Part I: The side-effects of Sandimmune that have been of most significance clinically are renal dysfunction, renal vascular damage and arterial hypertension. To examine the nature and the origin of such effects, the actions of Sandimmune on the renal tubule, the renal vessels and systemic vessels have been analyzed. To evaluate whether common vasoconstrictory systems may be involved, changes in the renin-angiotensin-aldosterone system and prostaglandin-thromboxane system have been assessed. Comparison between animal and human data obtained in vivo and in vitro shows the actions of Sandimmune on the renal tubule to be modest and involve only a few specific effects. The major action of Sandimmune is on the vessels, vasoconstriction being the major cause of renal dysfunction and also the cause of arterial hypertension. Neither the circulating renin-angiotension-aldosterone system nor the prostaglandin-thromboxane system is clearly responsible for vasoconstriction. Although not itself a vasoconstrictor, Sandimmune seems to modulate the constrictory and dilatory response to other agents in several vascular beds.

References

Aug 1, 1994·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·S A HultonT M Barratt
Sep 1, 1991·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·P F HoyerG Offner
Jan 17, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Birgitta KranzP F Hoyer
Mar 26, 2004·Transplantation Proceedings·D Abendroth
May 30, 2001·Transplantation Proceedings·M Kempkes-KochH Hohage
Sep 2, 1998·Transplantation Proceedings·J J Curtis
Mar 3, 1999·Journal of Chromatography. B, Biomedical Sciences and Applications·G I KirchnerK F Sewing
Jan 15, 1997·Transplantation·J LaineL Dunkel
Sep 1, 1994·European Journal of Clinical Investigation·C CedidiW G Forssmann
Jan 1, 1995·Clinical and Experimental Pharmacology & Physiology. Supplement·H F GrobeckerT Wellenhofer
Apr 1, 2003·Expert Opinion on Investigational Drugs·Jens W Eckstein, John Fung
Feb 1, 2006·Basic & Clinical Pharmacology & Toxicology·Enes Murat AtasoyuMustafa Gultepe
Aug 1, 1993·Immunopharmacology and Immunotoxicology·C Ponticelli
Apr 29, 1998·Annals of Medicine·J LaineC Holmberg
Mar 16, 2001·Expert Opinion on Pharmacotherapy·G CiancioJ Miller
Feb 27, 1999·Renal Failure·M TariqA Al Khader
Apr 1, 1996·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J LaineP Häyry
Feb 6, 1998·The Journal of Laboratory and Clinical Medicine·T ParraM Rodriguez-Puyol
Oct 15, 1998·The American Journal of Gastroenterology·K FellermannE F Stange
Nov 26, 1991·Klinische Wochenschrift·P HeeringB Grabensee
Oct 21, 2000·Renal Failure·M TariqA Al Khader
May 17, 2006·Molecular and Cellular Biochemistry·Anthony JosephinePalaninathan Varalakshmi
Feb 29, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J GalleC Wanner
Sep 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stanislaw M StepkowskiRobert A Kirken
Oct 29, 2011·Journal of Cellular Biochemistry·Roberto CiarciaAntonio Giordano

Citations

Jan 1, 1990·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·T P HannedoucheJ P Grünfeld
Apr 1, 1990·Kidney International·T P HannedoucheJ P Grünfeld
Jun 1, 1990·Kidney International·V KonR L Hoover
Dec 1, 1989·Journal of Internal Medicine·T J StoofA J Donker
Jun 1, 1989·The Journal of Surgical Research·R A RosenthalK U Kahng
Jan 1, 1989·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M SabbatiniV E Andreucci
Jan 1, 1989·Renal Failure·L J BrunnerD R Luke
Apr 1, 1989·Hypertension·H Meyer-Lehnert, R W Schrier
May 1, 1989·The American Journal of Cardiology·P HeldM Yacoub
Aug 3, 1989·The New England Journal of Medicine·H Y LinI H Fox
Jun 8, 1989·European Journal of Pharmacology·C BossallerE Fleck
Aug 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·E Müller-Schweinitzer
Jul 1, 1989·Biochemical Pharmacology·A ErmanJ Rosenfeld
Jun 1, 1985·Lancet·R D AllenP J Morris
Nov 8, 1986·Lancet·G DerayA Caraillon
Jan 1, 1988·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·G O Evans
Mar 1, 1989·The Journal of Clinical Investigation·S C ThomsonR C Blantz
Dec 12, 1986·JAMA : the Journal of the American Medical Association·C N EllisT M Annesley
Mar 1, 1987·Biochemical Pharmacology·F T McAuleyJ G Simpson
Aug 1, 1988·The American Journal of Medicine·J J CurtisA G Diethelm
Nov 1, 1988·European Journal of Pediatrics·F KrullJ Brodehl
Feb 1, 1986·European Journal of Clinical Investigation·H DieperinkE Kemp
Sep 15, 1987·Biochemical and Biophysical Research Communications·A KurtzK M Koch
Aug 1, 1987·British Medical Journal·J FeehallyP R Bell
Dec 1, 1987·European Journal of Clinical Investigation·H DieperinkN Rossing
Jan 1, 1988·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·P F HoyerJ Brodehl

Related Concepts

Pulmonary Arterial Hypertension
Aldosterone Measurement
Pathologic Vasoconstriction
Blood Vessel
Cyclosporine
Renal Tubule Structure
Kidney
Entire Renal Tubule
Cyclosporine Measurement
Renal Blood Flow

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.